EBITDA (Annual)

EBITDA: Income before interest, taxes, depreciation and amortization.

Abbott Laboratories (ABT) had EBITDA of $10.04B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$41.95B
Net Income	$13.40B
Cost of Goods Sold	$18.71B
Gross Profit	$23.24B
Operating Expenses	$35.12B
Operating Income	$6.83B
Non-Operating Income/Expense	$188.00M
Pre-Tax Income	$7.01B
Normalized Pre-Tax Income	$7.01B
Income after Taxes	$13.40B
Income from Continuous Operations	$13.40B
Consolidated Net Income/Loss	$13.40B
Normalized Income after Taxes	$13.40B
EBIT	$6.83B
EBITDA	$10.04B
Weighted-Average Shares Outstanding (Basic)	1.74B
Weighted-Average Shares Outstanding (Diluted)	1.75B
Earnings per Share (EPS) (Basic)	$7.67
Earnings per Share (EPS) (Diluted)	$7.64
Balance Sheet Financials
Current Assets	$23.66B
Property, Plant, and Equipment	$10.66B
Long-Term Assets	$57.76B
Total Assets	$81.41B
Current Liabilities	$14.16B
Long-Term Debt	$12.62B
Long-Term Liabilities	$19.36B
Total Liabilities	$33.51B
Common Equity	$47.90B
Tangible Shareholders Equity	$18.15B
Shareholders Equity	$47.90B
Common Shares Outstanding	1.73B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$8.56B
Cash Flow from Investing Activities	$-2.34B
Cash Flow from Financial Activities	$-5.40B
Beginning Cash	$6.90B
End Cash	$7.62B
Increase/Decrease in Cash	$720.00M
Stock-Based Compensation	$673.00M
Common Stock Dividends Paid	$-3.84B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.67
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.21
Debt to Equity Ratio	0.29
Gross Margin	55.41%
Operating Margin	16.27%
EBIT Margin	16.27%
EBITDA Margin	23.94%
Pre-Tax Profit Margin	16.72%
Profit Margin	31.95%
Free Cash Flow	$6.35B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.52
Inventory Turnover	3.02
Receiveable Turnover	6.06
Days Sales in Receivables	60.25
Return on Equity	27.98%
Return on Tangible Equity	73.86%
Return on Assets	16.46%
Return on Investments	22.14%
Book Value Per Share	$27.66
Free Cash Flow per Share	$3.63
Operating Cash Flow per Share	$4.90

Data from Zacks Investment Research, Inc.